Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 3
2000 1
2002 5
2003 1
2004 4
2005 8
2006 8
2007 11
2008 8
2009 5
2010 3
2011 5
2012 6
2013 5
2014 8
2015 8
2016 14
2017 18
2018 4
2019 8
2020 3
2021 7
2022 5
2023 5
2024 7
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

147 results

Results by year

Filters applied: . Clear all
Page 1
[Ebola virus disease].
Nazimek K, Bociaga-Jasik M, Bryniarski K, Gałas A, Garlicki A, Gawda A, Gawlik G, Gil K, Kosz-Vnenchak M, Mrozek-Budzyn D, Olszanecki R, Piatek A, Zawilińska B, Marcinkiewicz J. Nazimek K, et al. Among authors: olszanecki r. Folia Med Cracov. 2014;54(3):5-16. Folia Med Cracov. 2014. PMID: 25694090 Free article. Review. Polish.
Mitochondria-targeted hydrogen sulfide donor reduces fatty liver and obesity in mice fed a high fat diet by inhibiting de novo lipogenesis and inflammation via mTOR/SREBP-1 and NF-κB signaling pathways.
Stachowicz A, Czepiel K, Wiśniewska A, Stachyra K, Ulatowska-Białas M, Kuśnierz-Cabala B, Surmiak M, Majka G, Kuś K, Wood ME, Torregrossa R, Whiteman M, Olszanecki R. Stachowicz A, et al. Among authors: olszanecki r. Pharmacol Res. 2024 Nov;209:107428. doi: 10.1016/j.phrs.2024.107428. Epub 2024 Sep 18. Pharmacol Res. 2024. PMID: 39303773 Free article.
Mitochondria-targeted hydrogen sulfide donor reduces atherogenesis by changing macrophage phenotypes and increasing UCP1 expression in vascular smooth muscle cells.
Stachowicz A, Wiśniewska A, Czepiel K, Pomierny B, Skórkowska A, Kuśnierz-Cabala B, Surmiak M, Kuś K, Wood ME, Torregrossa R, Whiteman M, Olszanecki R. Stachowicz A, et al. Among authors: olszanecki r. Biomed Pharmacother. 2024 Nov;180:117527. doi: 10.1016/j.biopha.2024.117527. Epub 2024 Oct 13. Biomed Pharmacother. 2024. PMID: 39405912 Free article.
Alterations in plasma proteome during acute COVID-19 and recovery.
Suski M, Olszanecka A, Stachowicz A, Kiepura A, Terlecki M, Madej J, Rajzer M, Olszanecki R. Suski M, et al. Among authors: olszanecki r. Mol Med. 2024 Aug 25;30(1):131. doi: 10.1186/s10020-024-00898-5. Mol Med. 2024. PMID: 39183264 Free PMC article.
The Influence of the FFAR4 Agonist TUG-891 on Liver Steatosis in ApoE-Knockout Mice.
Kiepura A, Suski M, Stachyra K, Kuś K, Czepiel K, Wiśniewska A, Ulatowska-Białas M, Olszanecki R. Kiepura A, et al. Among authors: olszanecki r. Cardiovasc Drugs Ther. 2024 Aug;38(4):667-678. doi: 10.1007/s10557-023-07430-7. Epub 2023 Jan 27. Cardiovasc Drugs Ther. 2024. PMID: 36705799 Free PMC article.
147 results